Olink Explore Cancer Biomarker Discovery Challenge

Olink is pleased to announce the Olink^® Explore Cancer Biomarker Discovery Challenge. This award covers the Olink Explore 3072 application and is valid only for researchers based in Europe. The Olink Cancer Biomarker Discovery Challenge is an exciting opportunity for early-stage career cancer researchers seeking to identify new biomarkers for the detection, characterization, and treatment of cancer.

Olink offers high quality protein biomarker discovery based on a flexible and scalable technology platform. Olink has taken proteomics to the next level by enabling high throughput, large scale analysis of thousands of proteins simultaneously, while using less than a drop of blood and maintaining exceptional levels of specificity, sensitivity, and dynamic range

Olink is inviting researchers to submit an abstract sharing their plans to use Olink Explore 3072 in their research. The goal of this program is to enable researchers in Europe to generate pilot data to submit in support of future grant applications, and to promote the use of cutting-edge solutions using Olink Explore 3072 for proteomics research.

Join the competition today>>